No connection

Features Terminal AI Assistant

Symbol search

/fundamentals

Enter to jump straight to the ticker page.

Search Results

Regulation Score 85 Neutral

Compass Pathways (CMPS): What Will Come Out of FDA Review Meeting for Depression Drug Candidate COMP360?

Mar 25, 2026 18:10 UTC

CMPS, XLV, IBB

Short term

Compass Pathways (CMPS): What Will Come Out of FDA Review Meeting for Depression Drug Candidate COMP360?.

Share this article

Article Stats

Impact

85

Sentiment

Neutral

Type

Regulation

Horizon

Short

Risk Level

High

Affected Symbols

Intelligence Terminal Fundamental Analysis Ask AI About This Advanced Chart More News

Intelligence Terminal Fundamental Analysis Ask AI About This Advanced Chart More News

Intelligence Terminal Fundamental Analysis Ask AI About This Advanced Chart More News

Analyze This News with AI

AI will analyze the impact on affected symbols and provide trading insights

Unlock Premium

Get AI-powered insights, advanced filtering, real-time alerts, and unlimited analysis.

Unlimited AI market analysis
Advanced news filtering
Real-time price alerts
AI trading assistant

View Plans Sign Up Free

Related Articles

Score 75 Bullish

Hong Kong Mulls Tax Exemption for Fund Managers to Boost Hub

Mar 27, 06:47

Score 72 Bearish

Australia Ramps Up Private Credit Scrutiny, Demanding More Data

Mar 27, 02:55

Score 85 Bearish

Japan to Allow More Coal-Fired Power to Cope With Energy Shock

Mar 27, 02:55

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Get Started Free View Plans